It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
In the last decade, a revolution in liquid chromatography-mass spectrometry (LC-MS) based proteomics was unfolded with the introduction of dozens of novel instruments that incorporate additional data dimensions through innovative acquisition methodologies, in turn inspiring specialized data analysis pipelines. Simultaneously, a growing number of proteomics datasets have been made publicly available through data repositories such as ProteomeXchange, Zenodo and Skyline Panorama. However, developing algorithms to mine this data and assessing the performance on different platforms is currently hampered by the lack of a single benchmark experimental design. Therefore, we acquired a hybrid proteome mixture on different instrument platforms and in all currently available families of data acquisition. Here, we present a comprehensive Data-Dependent and Data-Independent Acquisition (DDA/DIA) dataset acquired using several of the most commonly used current day instrumental platforms. The dataset consists of over 700 LC-MS runs, including adequate replicates allowing robust statistics and covering over nearly 10 different data formats, including scanning quadrupole and ion mobility enabled acquisitions. Datasets are available via ProteomeXchange (PXD028735).
Measurement(s) | Digital Data Repository |
Technology Type(s) | Digital Data Repository |
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details






1 Ghent University, ProGenTomics, Laboratory of Pharmaceutical Biotechnology, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)
2 Max Planck Institute of Biochemistry, Department of Proteomics and Signal Transduction, Martinsried, Germany (GRID:grid.418615.f) (ISNI:0000 0004 0491 845X)
3 VIB-UGent Center for Medical Biotechnology, VIB, Ghent, Belgium (GRID:grid.511525.7); Ghent University, Department of Biomolecular Medicine, Ghent, Belgium (GRID:grid.5342.0) (ISNI:0000 0001 2069 7798)
4 Université de Toulouse, CNRS, UPS, Institut de Pharmacologie et de Biologie Structural (IPBS), Toulouse, France (GRID:grid.15781.3a) (ISNI:0000 0001 0723 035X)
5 VITO Health, Mol, Belgium (GRID:grid.6717.7) (ISNI:0000000120341548); University of Antwerpen, Centre for Proteomics, Antwerp, Belgium (GRID:grid.5284.b) (ISNI:0000 0001 0790 3681)
6 Waters Corporation, Wilmslow, UK (GRID:grid.5284.b)
7 Wellcome Genome Campus, European Molecular Biology Laboratory, European Bioinformatics Institute, Hinxton, UK (GRID:grid.52788.30) (ISNI:0000 0004 0427 7672)
8 SCIEX, Concord, Ontario, Canada (GRID:grid.292651.b) (ISNI:0000 0004 0641 7691)